证券记录 · 已归档季度
NVST
Envista Holdings Corp · Healthcare · Medical - Instruments & Supplies
14被追踪持有人
+1Δ持有人
30.02M持有股份
$593.21M报告持仓市值
+1新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +7.7% ·
股份流向 +24.6% ·
净新建仓位 +7.1%
— 公式
广泛积累 — 持股数量上升且持有人增多
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 107 | -2 | 135.18M | $3.46B | +8 | −10 |
| Q1 2026 | 112 | +2 | 125.88M | $3.08B | +10 | −9 |
| Q4 2025 | 111 | +1 | 135.55M | $2.86B | +3 | −1 |
| Q3 2025 | 20 | 0 | 79.00M | $1.61B | +1 | −2 |
| Q2 2025 | 18 | +2 | 64.07M | $1.25B | +2 | — |
| Q1 2025 | 13 | -2 | 25.86M | $445.80M | — | −2 |
| Q4 2024 | 15 | 0 | 32.49M | $626.68M | — | — |
| Q3 2024 | 14 | +1 | 30.02M | $593.21M | +1 | — |
| Q2 2024 | 13 | — | 24.10M | $400.73M | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Harris Associates (Oakmark) ✦ | 10.49M | -2.7% | $207.20M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 2 | Harris Associates (Oakmark) ✦ | 10.49M | -2.7% | $207.20M | 0.3% | ▼ Trim | 2 | SEC ↗ |
| 3 | Citadel Advisors ✦ | 6.12M | +555.6% | $121.00M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 6.12M | +555.6% | $121.00M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (被动) | 2.90M | +2.5% | $57.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 2.90M | +2.5% | $57.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Norges Bank ✦ (被动) | 1.99M | +0.6% | $39.34M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Point72 Asset Management ✦ | 1.90M | 新增 | $37.56M | 0.1% | New | 1 | SEC ↗ |
| 9 | Tweedy, Browne ✦ | 1.89M | -0.8% | $37.30M | 1.8% | ▼ Trim | 2 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 1.24M | -16.0% | $24.47M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | AQR Capital Management ✦ | 1.24M | -16.0% | $24.47M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 1.24M | -16.0% | $24.47M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Gotham Asset Management ✦ | 989.12K | +328.7% | $19.54M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 14 | Marshall Wace ✦ | 928.39K | -17.8% | $18.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Marshall Wace ✦ | 928.39K | -17.8% | $18.35M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 608.88K | -38.9% | $12.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 608.88K | -38.9% | $12.03M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | Renaissance Technologies ✦ | 601.20K | -8.3% | $11.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Millennium Management ✦ | 201.90K | -80.3% | $3.99M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | T. Rowe Price ✦ | 140.97K | +1.1% | $2.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 26.55K | -16.6% | $524,727 | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $37.56M | 0.1% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 10 持有人, 12.46M 股份, $12.36M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 20
Reis Mischa
Officer · 8.00K 股 · $220,000
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据